ALIMTA Trademark

Trademark Overview

On Monday, February 2, 1998, a trademark application was filed for ALIMTA with the United States Patent and Trademark Office. The USPTO has given the ALIMTA trademark a serial number of 75427790. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, March 13, 2021. This trademark is owned by Eli Lilly and Company. The ALIMTA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for treatment of cancer
alimta

General Information

Serial Number75427790
Word MarkALIMTA
Filing DateMonday, February 2, 1998
Status800 - REGISTERED AND RENEWED
Status DateSaturday, March 13, 2021
Registration Number2414358
Registration DateTuesday, December 19, 2000
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 1, 1998

Trademark Statements

Goods and Servicespharmaceutical preparations for treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 17, 1998
Primary Code005
First Use Anywhere DateMonday, May 15, 2000
First Use In Commerce DateMonday, May 15, 2000

Trademark Owner History

Party NameEli Lilly and Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Saturday, March 13, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, March 13, 2021REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Saturday, March 13, 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, March 13, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, December 3, 2020TEAS SECTION 8 & 9 RECEIVED
Friday, October 8, 2010REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, October 8, 2010REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, October 6, 2010TEAS SECTION 8 & 9 RECEIVED
Friday, February 2, 2007REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, February 1, 2007ASSIGNED TO PARALEGAL
Monday, December 4, 2006REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Monday, December 4, 2006TEAS SECTION 8 & 15 RECEIVED
Monday, July 24, 2006CASE FILE IN TICRS
Tuesday, December 19, 2000REGISTERED-PRINCIPAL REGISTER
Monday, August 14, 2000ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 8, 2000ASSIGNED TO EXAMINER
Friday, August 4, 2000STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 1, 2000USE AMENDMENT FILED
Tuesday, December 21, 1999NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 8, 1998EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, December 1, 1998PUBLISHED FOR OPPOSITION
Friday, October 30, 1998NOTICE OF PUBLICATION
Saturday, September 19, 1998APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 17, 1998ASSIGNED TO EXAMINER

Related Keywords

alimta cancer treatment preparations pharmaceutical